Described as “much-needed reform around claims language, drug preclusion, and federal supremacy clause reform to forestall state-by-state regulation over supplements,” take a look at “DSHEA 10.0.”
Needed transparency tool...or burdensome requirement that won’t protect consumers from bad actors? The debate over mandatory product listing for dietary supplements continues.
AHPA, CRN, and NPA react to the introduction of the Dietary Supplement Listing Act of 2026, renewing a debate within the natural products industry over the role of a mandatory product listing and dietary supplement oversight.
With 2025 data highlighting widespread consumer use and value in supplements, CHPA outlines a comprehensive approach to protect consumers, build trust, and strengthen the supplement industry.
Get updated on key takeaways, plus a call to action to help advance the industry’s goals and ensure dietary supplements remain a vital part of the nutrition and wellness conversation.
Day on the Hill will provide members with an opportunity to meet with Members of Congress and Congressional staff to discuss policy priorities for the dietary supplement and functional food industry.
The Dietary Supplement Listing Act of 2024, which would require dietary supplement manufacturers to list their products with the Food and Drug Administration (FDA).
NPA's 2024 Fly-In Day saw the largest attendance since post-pandemic, with retailers, brands, suppliers, and industry stakeholders advocating for the future of the natural products industry.
Legislation (HR 8123) introduced by Representative Frank Pallone (D-NJ) and Senator Dick Durbin (D-IL)aims to amend the Federal Food, Drug, and Cosmetic Act to establish new prohibited acts relating to dietary supplements.
The modernization of DSHEA and mandatory product listingfor dietary supplements as been a hot topic in the natural products industry for years. Here's the latest.
